<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159936">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02119494</url>
  </required_header>
  <id_info>
    <org_study_id>205.529</org_study_id>
    <nct_id>NCT02119494</nct_id>
  </id_info>
  <brief_title>Phenotypes of COPD in Central and Eastern Europe</brief_title>
  <acronym>POPE</acronym>
  <official_title>POPE-Study: Phenotypes Of COPD in Central and Eastern Europe Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zuzana Zbožínková, M.Sc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boehringer Ingelheim</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Masaryk University</source>
  <oversight_info>
    <authority>Czech Republic: State Institute for Drug Control</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the representation of COPD patients in terms of
      categories and phenotypes of the disease in selected countries in Central and Eastern Europe
      (CEE). The results of The POPE study will allow for evaluation of the differences in
      clinical approaches and treatment practices. The following countries are represented in The
      POPE study: Czech Republic, Slovakia, Austria, Poland, Hungary, Russia, Croatia, Serbia,
      Slovenia, Estonia, Latvia and Bulgaria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic Obstructive Pulmonary Disease (COPD) is a significant cause of morbidity and
      mortality in Europe and a major consumer of resources in both primary and secondary
      healthcare (1,2). Both clinical features of disease severity and quality of COPD patient
      care may have substantial influence on disease outcomes. Traditionally, COPD has been
      categorized using the FEV1 (forced expiratory volume at one second ) - based GOLD (The
      Global Initiative for Chronic Obstructive Lung Disease) classification . Other factors
      independently associated with survival include age, dyspnoea, health status, hyperinflation,
      gas exchange abnormalities, exacerbation frequency, exercise capacity, pulmonary
      hemodynamic, and nutritional status (3). Together these factors explain some of the existent
      heterogeneity within each GOLD stage in terms of symptoms, exacerbations, quality of life
      and exercise capacity (4).

      Recently, interest has emerged for the identification of clinical COPD phenotypes, as
      defined by ''a single or combination of disease attributes that describe difference between
      individuals with COPD as they relate to clinically meaningful outcomes'' (5).  Many previous
      studies have attempted to identify and quantify the prevalence of different phenotypes of
      COPD using populations of various sources, severities, and particularities. Yet there is no
      consensus on the number and definition of different phenotypes. However, there must be a
      compromise between the oversimplification of the term COPD as a definition that encompasses
      the entire spectrum of patients with incompletely reversible airflow obstruction caused
      largely by smoking and the complexity of considering each patient individually as an orphan
      disease.

      The most frequently reported phenotypes are emphysema and chronic bronchitis, along with a
      subset of asthma sufferers. Recently, an extended list of proposed phenotypes have been
      proposed (6) including: (A) infrequent exacerbators with either chronic bronchitis or
      emphysema; (B) overlap COPD-asthma; (C) frequent exacerbators with emphysema predominant;
      and (D) frequent exacerbators with chronic bronchitis predominant. While there is consensus
      of substantial, but not complete, overlap among these phenotypes, the distribution of these
      phenotypes may differ widely between different countries and healthcare systems.

      Thus, the objectives of this study are to better understand the patient characteristics and
      treatment patterns of those diagnosed with COPD between different CEE countries. Knowledge
      of this information may provide insight into the variability of phenotypes between different
      healthcare systems and may subsequently contribute to a better understanding of the factors
      associated with patient outcomes and have the potential to improve the care of COPD
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <target_duration>7 Months</target_duration>
  <primary_outcome>
    <measure>The distribution of COPD patients according to GOLD 2011 grades</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 classifies patients according to airflow limitation into four grades: GOLD1, Mild; GOLD 2, Moderate; GOLD 3, Severe;  GOLD 4, Very severe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The distribution of COPD patients according to GOLD 2011 categories of risk (A. B, C, D)</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prevalence of various COPD phenotypes</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The COPD phenotypes are: bronchitis, emphysema phenotype, frequent exacerbators, pulmonary cachexia, COPD and asthma overlap, and COPD and bronchiectasis overlap</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence various medication prescription</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence of long term oxygen therapy use</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The prevalence of surgical treatments in COPD patients</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The use of body plethysmography, bronchodilator test, carbon monoxide diffusing capacity testing,  bronchial challenge test and FeNO test in ambulatory care</measure>
    <time_frame>7 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COPD who visit selected specialised pulmonology clinics in the given time
        period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 40 years

          2. Clinical diagnosis of COPD with post-bronchodilator FEV1/FVC &lt;  0.7

          3. Smoking burden ≥ 10 pack-years in smokers (group A). Evidence of exposure to at least
             one other typical inhaled COPD risk factor: environmental tobacco smoke, professional
             exposures, etc. (group B)
                                                                Each country will include 300 COPD
             subjects with positive history of smoking (at least 10 pack-years). Consecutive
             non-smokers with COPD can be enrolled above this limit. Institute for Biostatistics
             and Analyses, Masaryk University, Brno, The Czech Republic will analyze both COPD
             groups (A and B) separately

          4. Stable disease for at least 4 weeks

          5. Outpatient status

          6. Informed Consent

        Exclusion Criteria:

          1. Exacerbation of COPD and/or instable co-morbid condition

          2. Patient during hospital stay for whatever reason (lung or co-morbidities)

          3. Patient is not able and willing to participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arschang Valipour, Assoc. Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Wiener Krankenanstaltenverbund</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vladimir Koblizek, MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruzena Tkacova, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Pavol Jozef Šafárik University in Košice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neven Tudoric, Prof., MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University of Zagreb, Clinical Hospital Dubrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyrill Zykov, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Moscow State University of Medicine and Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Attila Somfay, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Szeged, Faculty of Medicine, Dept. of Pulmonology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adam Barczyk, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Miravitlles, Prof., MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'Hebron Barcelona, Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zuzana Zbozinkova, M.Sc</last_name>
    <phone>+420 549 49 8510</phone>
    <email>zbozinkova@iba.muni.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pulmonary Medicine, LKH Hohenems</name>
      <address>
        <city>Hohenems</city>
        <zip>A-6845</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>AKH Linz, Department of Pulmonary Medicine</name>
      <address>
        <city>Linz</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pulmonary Rehabilitation Centre, Therme Wien</name>
      <address>
        <city>Vienna</city>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for pneumonology and phisiatry, UMHAT &quot;Dr. Georgi Stranski&quot;</name>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Respiratory Diseases, Medical University</name>
      <address>
        <city>Plovdiv</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Internal Medicine, Pulmonary diseases and Clinical Allergology, Medical Institute of Ministry of Interior</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pulmonary Diseases Clinic, Military Medical Academy</name>
      <address>
        <city>Sofia</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Pulmonology, MHAT &quot;st. Marina&quot;</name>
      <address>
        <city>Varna</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika za plućne bolesti</name>
      <address>
        <city>Dubrava</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika za unutarnje bolesti</name>
      <address>
        <city>Osijek</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika za internu medicinu</name>
      <address>
        <city>Rijeka</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika za unutarnje bolesti</name>
      <address>
        <city>Split</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika za plućne bolesti Jordanovac</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pulmonary Outpatient Clinic, University Hospital Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <zip>500 05</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Karlovy Vary</name>
      <address>
        <city>Karlovy Vary</city>
        <zip>36066</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Ostrava Poruba</name>
      <address>
        <city>Ostrava</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Plicní ambulance Teplice</name>
      <address>
        <city>Teplice</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baja Szent Rókus Kórház Tüdőbeteggondozó Intézet</name>
      <address>
        <city>Baja</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szabolcs- Szatmár-Bereg Megyei Kórházak és Egyetemi Oktató Kórház</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Újpesti Egészségügyi Nonprofit Szolgáltató Kft</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Egyesített Egészségügyi Intézmények Tüdőgondozó Intézete</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Romics László Egészségügyi Intézmény Tüdőgondozó</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Erzsébet Gondozóház Kft</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jászberény Szent Erzsébet Kórház Tüdőgondozó Intézet</name>
      <address>
        <city>Jászberény</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szarvasi Tüdőgyógyász KFT (ő az ügyvezető igazgató)</name>
      <address>
        <city>Szarvas</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>IZOPULM Egészségügyi szolgáltató Kft.</name>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Csongrád Megyei Mellkasi Betegségek Szakkórháza</name>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oddział Chorób Płuc i Niewydolności Oddychania, Kujawsko - Pomorskie; Centrum Pulmonologii w Bydgoszczy</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-326</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika Alergologii i Pneumonologii, Uniwersyteckie Centrum Kliniczne, Szpital Gdańskiego Uniwersytetu Medycznego,</name>
      <address>
        <city>Gdansk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny</name>
      <address>
        <city>Katowice</city>
        <zip>40-752</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki, Oddział Kliniczny Kliniki Pulmonologii</name>
      <address>
        <city>Krakow</city>
        <zip>31-066</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika Pneumonologii i Alergologii Uniwersytetu Medycznego w Łodzi</name>
      <address>
        <city>Lodz</city>
        <zip>90-153</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Pulmonologii, Alergologii i Onkologii Pulmonologicznej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu</name>
      <address>
        <city>Poznan</city>
        <zip>60-569</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii, Samodzielny Publiczny Centralny Szpital Kliniczny Warszawski Uniwersytet Medyczny,</name>
      <address>
        <city>Warsaw</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oddział Chorób Płuc VIA Katedra i Klinika Pulmonologii i Nowotworów Płuc Uniwersytetu Medycznego we Wrocławiu, Dolnośląskie Centrum Chorób Płuc we Wrocławiu</name>
      <address>
        <city>Wroclaw</city>
        <zip>53-439</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Centre of Serbia</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Municipal Institute for Lung Diseases and Tuberculosis</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Centre Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for Pulmonary Diseases, Clinical Center of Nis</name>
      <address>
        <city>Nis</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institute for Pulmonary Diseases and TB, Clinical Centre Vojvodina</name>
      <address>
        <city>Novi Sad</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>FNsP F.D. Roosevelta</name>
      <address>
        <city>Banská Bystrica</city>
        <zip>97517</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>NsP Sv. Jakuba</name>
      <address>
        <city>Bardejov</city>
        <zip>085 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zdravotné stredisko Fedinova</name>
      <address>
        <city>Bratislava</city>
        <zip>85101</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika pneumológie a ftizeológie LF SZU a UNB,</name>
      <address>
        <city>Bratislava</city>
        <zip>821 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ambulancia pneumológie a ftizeológie, ZAPA JJ s.r.o.,</name>
      <address>
        <city>Levice</city>
        <zip>934 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika tubekulózy a respiračných chorôb JLF UK a UNM</name>
      <address>
        <city>Martin</city>
        <zip>036 59</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dionea, s.r.o.</name>
      <address>
        <city>Nové Zámky</city>
        <zip>94001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pľúcna ambulancia</name>
      <address>
        <city>Poprad</city>
        <zip>05801</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>NsP</name>
      <address>
        <city>Považská Bystrica</city>
        <zip>017 26</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zdravotné stredisko Rimava</name>
      <address>
        <city>Rimavská Sobota</city>
        <zip>979 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Bulgaria</country>
    <country>Croatia</country>
    <country>Czech Republic</country>
    <country>Hungary</country>
    <country>Poland</country>
    <country>Serbia</country>
    <country>Slovakia</country>
  </location_countries>
  <reference>
    <citation>Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010 Mar 22;170(6):560-5. doi: 10.1001/archinternmed.2010.17. Erratum in: Arch Intern Med. 2010 Jun 28;170(12):1023.</citation>
    <PMID>20308643</PMID>
  </reference>
  <reference>
    <citation>Menn P, Heinrich J, Huber RM, Jörres RA, John J, Karrasch S, Peters A, Schulz H, Holle R; KORA Study Group. Direct medical costs of COPD--an excess cost approach based on two population-based studies. Respir Med. 2012 Apr;106(4):540-8. doi: 10.1016/j.rmed.2011.10.013. Epub 2011 Nov 18.</citation>
    <PMID>22100535</PMID>
  </reference>
  <reference>
    <citation>Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2005 Mar;11(2):149-52. Review.</citation>
    <PMID>15699788</PMID>
  </reference>
  <reference>
    <citation>Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010 Sep 10;11:122. doi: 10.1186/1465-9921-11-122.</citation>
    <PMID>20831787</PMID>
  </reference>
  <reference>
    <citation>Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604. doi: 10.1164/rccm.200912-1843CC. Epub 2010 Jun 3.</citation>
    <PMID>20522794</PMID>
  </reference>
  <reference>
    <citation>Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Piñera P, Simón A, Riesco JA, Ancochea J, Soriano JB. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J. 2013 Mar;22(1):117-21. doi: 10.4104/pcrj.2013.00016.</citation>
    <PMID>23443227</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 20, 2014</lastchanged_date>
  <firstreceived_date>April 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Masaryk University</investigator_affiliation>
    <investigator_full_name>Zuzana Zbožínková, M.Sc.</investigator_full_name>
    <investigator_title>project manager</investigator_title>
  </responsible_party>
  <keyword>chronic obstructive pulmonary disease</keyword>
  <keyword>phenotypes</keyword>
  <keyword>categories</keyword>
  <keyword>stage</keyword>
  <keyword>GOLD</keyword>
  <keyword>treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
